PLUS1
162.98
0.60 (0.37%)
0.60 (0.37%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | JNJ | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.60 | 0.37% | 162.98 | 09:19:28 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 162.38 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 597 | 23,721 | 7,712,976 | 109.16 - 164.14 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:21:39 | 1 | $ 162.98 | USD |
Johnson and Johnson Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 429.05B | 2.63B | 2.63B | $ 82.06B | $ 17.72B | 5.63 | 25.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 3.75 | 2.30% | - | - |
Johnson and Johnson News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/21/2021 | 06:43 | Dow Jones News | Addex Therapeutics, Janssen Gets FDA Approval to Begin Proof.. |
| 1/13/2021 | 17:50 | Dow Jones News | Favorable Data Published About Johnson & Johnson Covid-19.. |
| 1/12/2021 | 20:35 | Dow Jones News | J&J Opposes Former Talc Supplier's Bankruptcy Plan to.. |
| 1/07/2021 | 10:43 | TipRanks | Jonhson & Jonhson’s Single-Dose Vaccine Could Be Approved by.. |
| 1/04/2021 | 08:30 | PR Newswire (US) | Johnson & Johnson Announces Quarterly Dividend for First.. |
| 12/21/2020 | 16:53 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) |
| 12/18/2020 | 08:19 | Dow Jones News | MacroGenics In Research, License Agreement With Janssen |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JNJ Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 160.45 | 164.14 | 159.1058 | 161.50 | 8,380,807 | 2.53 | 1.58% |
| 1 Month | 151.85 | 164.14 | 151.82 | 158.89 | 7,192,399 | 11.13 | 7.33% |
| 3 Months | 138.00 | 164.14 | 133.65 | 150.78 | 7,622,123 | 24.98 | 18.1% |
| 6 Months | 149.75 | 164.14 | 133.65 | 149.44 | 6,665,325 | 13.23 | 8.83% |
| 1 Year | 148.58 | 164.14 | 109.16 | 144.43 | 8,092,971 | 14.40 | 9.69% |
| 3 Years | 147.01 | 164.14 | 109.16 | 137.80 | 7,355,627 | 15.97 | 10.86% |
| 5 Years | 95.77 | 164.14 | 94.28 | 132.16 | 6,716,687 | 67.21 | 70.18% |
Johnson and Johnson Description
| Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States. |
